Can TransMedics Group, Inc. cover its short-term obligations?

Its current ratio is 6.74 — current assets exceed current liabilities.

Where does TransMedics Group, Inc.'s balance sheet data come from?

Every line is extracted from TransMedics Group, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

TransMedics Group, Inc. TMDX Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Cash and cash equivalents	$461.74M-5.5%	$488.37M+4.8%	$466.17M+16.4%	$400.58M+29.2%	$310.14M-7.9%
Restricted cash	$18.44M+3,588%	$500K0.0%	$500K0.0%	$500K0.0%	$500K0.0%
Accounts receivable, net	$90.73M+7.6%	$84.28M+4.4%	$80.7M-23.0%	$104.85M-26.2%	$142.03M+45.3%
Inventories	$49.89M+2.1%	$48.88M+9.8%	$44.51M+14.5%	$38.87M-10.4%	$43.38M-6.8%
Prepaid expenses and other current assets	$16.92M+4.1%	$16.25M-24.8%	$21.61M+56.2%	$13.84M+33.4%	$10.37M-36.3%
Total current assets	$619.28M-2.9%	$637.78M+4.0%	$613M+9.8%	$558.13M+10.3%	$505.92M+1.8%
Property and equipment, net	$361.57M+10.4%	$327.66M+4.7%	$313.02M+0.2%	$312.26M+0.3%	$311.24M+8.8%
Operating lease right-of-use assets	$4.86M-5.8%	$5.16M-10.2%	$5.74M-1.3%	$5.82M-3.1%	$6.01M-7.3%
Goodwill	$11.55M0.0%	$11.55M0.0%	$11.55M0.0%	$11.55M0.0%	$11.55M0.0%
Intangible assets, net	$0-100%	$1.95M-2.6%	$2M-2.5%	$2.05M-2.4%	$2.1M-2.4%
Deferred tax assets	$124.25M+495%	$20.89M—	——	——	——
Other non-current assets	$2.1M+780%	$239K+5.8%	$226K+2.3%	$221K+4.7%	$211K+1.4%
Total assets	$1.43B+34.3%	$1.07B+12.9%	$946.03M+6.2%	$890.52M+6.3%	$837.53M+4.2%
Accounts payable	$11.15M+7.7%	$10.35M-14.9%	$12.16M+27.5%	$9.54M-10.0%	$10.6M+2.9%
Accrued expenses	$59.32M-5.5%	$62.74M+12.0%	$56.02M+31.8%	$42.49M+5.9%	$40.14M-11.1%
Deferred revenue	$2.95M+1.4%	$2.91M-12.1%	$3.31M+111%	$1.57M-24.4%	$2.08M+19.3%
Current portion of long-term debt	——	——	——	——	——
Operating lease liabilities, current	$3.51M+6.0%	$3.31M+2.2%	$3.24M+7.2%	$3.02M+8.2%	$2.79M+2.3%
Total current liabilities	$91.92M+2.9%	$89.31M+12.0%	$79.72M+40.8%	$56.62M+1.8%	$55.6M-7.2%
Long-term debt	$44.67M-9.9%	$49.59M-9.2%	$54.6M-8.3%	$59.53M+0.1%	$59.45M+0.1%
Operating lease liabilities, non-current	$2.88M-19.4%	$3.58M-19.2%	$4.43M-9.9%	$4.91M-11.0%	$5.52M-11.6%
Finance Lease Liabilities (Total)	——	——	——	——	——
Operating Lease Liabilities (Total)	——	——	——	——	——
Finance lease liabilities	——	——	——	——	——
Other non-current liabilities	——	——	——	——	——
Total liabilities	$940.81M+58.0%	$595.27M+0.8%	$590.83M+3.2%	$572.42M+0.2%	$571.22M-0.7%
Preferred stock	——	——	——	——	——
Common stock	$764.64M+1.8%	$750.93M+1.7%	$738.43M+1.8%	$725.66M+2.3%	$709.19M+1.7%
Retained earnings	-$270.64M+2.6%	-$277.95M+27.5%	-$383.33M+6.0%	-$407.65M+7.9%	-$442.56M+5.5%
Accumulated other comprehensive income (loss)	$2K-98.4%	$124K+22.8%	$101K+3.1%	$98K+130%	-$327K+10.2%
Total stockholders' equity	$494.01M+4.4%	$473.1M+33.2%	$355.2M+11.7%	$318.1M+19.4%	$266.31M+16.5%
Total liabilities and stockholders' equity	$1.43B+34.3%	$1.07B+12.9%	$946.03M+6.2%	$890.52M+6.3%	$837.53M+4.2%
Deferred Tax Assets and Other Non-Current Assets	$2.1M+780%	$239K+5.8%	$226K+2.3%	$221K+4.7%	$211K+1.4%
Net Investment in Lease	$4.86M-5.8%	$5.16M-10.2%	$5.74M-1.3%	$5.82M-3.1%	$6.01M-7.3%
Deferred tax assets	——	——	——	——	——
Other intangible assets—net	$0-100%	$1.95M-2.6%	$2M-2.5%	$2.05M-2.4%	$2.1M-2.4%
Operating lease right-of-use assets	$4.86M-5.8%	$5.16M-10.2%	$5.74M-1.3%	$5.82M-3.1%	$6.01M-7.3%
Other non-current assets	$2.1M+780%	$239K+5.8%	$226K+2.3%	$221K+4.7%	$211K+1.4%
Operating Lease Right-of-Use Assets in Other Assets	$4.86M-5.8%	$5.16M-10.2%	$5.74M-1.3%	$5.82M-3.1%	$6.01M-7.3%
Software and Technology Licenses, Net	$2.1M+780%	$239K+5.8%	$226K+2.3%	$221K+4.7%	$211K+1.4%
Convertible Debt (Non-Current)	$453.53M+0.2%	$452.8M+0.2%	$452.08M+0.2%	$451.36M+0.2%	$450.65M+0.2%
Accrued expenses and other liabilities	$59.32M-5.5%	$62.74M+12.0%	$56.02M+31.8%	$42.49M+5.9%	$40.14M-11.1%
Total debt	$409.89M+517%	$66.47M-1.2%	$67.27M-0.3%	$67.46M-0.4%	$67.76M-0.9%
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$764.64M+1.8%	$750.93M+1.7%	$738.43M+1.8%	$725.66M+2.3%	$709.19M+1.7%
Convertible debentures	$453.53M+0.2%	$452.8M+0.2%	$452.08M+0.2%	$451.36M+0.2%	$450.65M+0.2%
Finance Lease, Right-of-Use Asset, after Accumulated Amortization	——	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Can TransMedics Group, Inc. cover its short-term obligations?: Its current ratio is 6.74 — current assets exceed current liabilities.
Where does TransMedics Group, Inc.'s balance sheet data come from?: Every line is extracted from TransMedics Group, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.